Understanding the acceptability, barriers and facilitators to implementing the 4CMenB vaccine for the prevention of gonorrhoea in gay, bisexual and other men who have sex with men

Background In November 2023, the Joint Committee on Vaccination and Immunisation advised the UK government that a targeted, opportunistic vaccination programme using 4CMenB to prevent gonorrhoea primarily in gay, bisexual and other men who have sex with men (GBMSM) at higher risk of infection should be introduced in sexual health services (SHSs). Data on the acceptability of 4CMenB vaccination and factors influencing uptake were needed. Methods Three focus group discussions (FGDs) were conducted with 17 GBMSM aged [≥]18 years, resident in England, who self-reported bacterial sexually transmitted infection or [≥]5 sexual partners in the previous 12 months. One FGD with five sexual healthc